or Try an Advanced Search...

    Technical Analysis for RPTX - Repare Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 2.84 -1.39% -0.04
    RPTX closed down 1.39 percent on Wednesday, November 20, 2024, on 78 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical RPTX trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -1.39%
    Older End-of-Day Signals for RPTX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 20 hours ago
    Up 2% about 20 hours ago
    Outside Day about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    RPTX Chart by TradingView
    Basic chart:

    Profile

    Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality

    Is RPTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Industry Analysts Just Made A Notable Upgrade To Their Repare Therapeutics Inc. (NASDAQ:RPTX) Revenue Forecasts
    Nov 12 Repare Therapeutics collaborates with U.S. National Cancer Institute
    Nov 12 Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
    Nov 7 Repare Therapeutics GAAP EPS of -$0.81
    Nov 7 Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
    Oct 24 Repare Therapeutics’ individualised anaemia management trial shows promise
    Oct 23 Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial
    Oct 15 RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
    Oct 14 Repare Therapeutics doses first subject in Phase I solid tumour trial
    Oct 14 Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
    See more RPTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.49
    52 Week Low 2.71
    Average Volume 123,227
    200-Day Moving Average 3.91
    50-Day Moving Average 3.41
    20-Day Moving Average 3.40
    10-Day Moving Average 3.25
    Average True Range 0.24
    RSI (14) 34.64
    ADX 26.05
    +DI 17.41
    -DI 28.54
    Chandelier Exit (Long, 3 ATRs) 3.32
    Chandelier Exit (Short, 3 ATRs) 3.48
    Upper Bollinger Bands 3.96
    Lower Bollinger Band 2.84
    Percent B (%b) 0.0
    BandWidth 32.89
    MACD Line -0.12
    MACD Signal Line -0.03
    MACD Histogram -0.0914
    Fundamentals Value
    Market Cap 119.65 Million
    Num Shares 42.1 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -1.23
    Price-to-Sales 6.17
    Price-to-Book 1.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.07
    Resistance 3 (R3) 3.08 3.02 3.03
    Resistance 2 (R2) 3.02 2.96 3.01 3.01
    Resistance 1 (R1) 2.93 2.93 2.90 2.92 3.00
    Pivot Point 2.87 2.87 2.86 2.86 2.87
    Support 1 (S1) 2.78 2.81 2.75 2.77 2.68
    Support 2 (S2) 2.72 2.78 2.71 2.67
    Support 3 (S3) 2.63 2.72 2.65
    Support 4 (S4) 2.62